Pyriproxyfen Suspected of Causing Microcephaly in Brazil
by Marco Cáceres,

A report published by Médicos de Pueblos Fumigados (Physicians in the Crop-Sprayed Villages) of Argentina on February 3, 2016 discounts the theory ...
GSK Business Strategy Based on Selling Lots of Vaccines
by TVR Staff

In its latest effort to increase its sales volume for vaccines and other pharmaceutical products, GlaxoSmithKline (GSK) of Great Britain has officially ...
U.S. Vaccine Market Forecast at $17.4 Billion by 2018
by TVR Staff

The value of the market for vaccines in the United States will reach $17.4 billion in 2018, according to a study published ...
Doctors Are No Experts on Vaccines
by Marco Cáceres

There is a common belief that doctors are "experts" on vaccines and vaccination. Almost nothing could be further from the truth. The ...
Nominee for FDA Commissioner Has Pharma Industry Ties
by Marco Cáceres

If confirmed by Congress, the next commissioner of the U.S. Food and Drug Administration (FDA) will be Robert M. Califf, MD. Dr ...
The Moran Team Study of 480 “Anti-Vax” Websites
by Marco Cáceres

A story circulating on the Internet is publicizing a new study that concludes much of the information on anti-vaccination websites promote "unscientific ...
Peer Review Process in Academic Publishing Untrustworthy
by Rishma Parpia

The peer review process is known to be the pride of the rigorous academic publishing process. It is a critical component used ...
Scientific Publishing Industry Has Become An Oligopoly
by Rishma Parpia

The flow of scientific research has significantly metamorphosed in the last 40 years. The content and production of published scientific research in ...
In this section
Latest
Popular
Comments
Latest
Popular
Comments
Rene on CDC Says Overweight People Need Longer Needles for Vaccinations
Susan Gruener on 15-Month-Old Girl Dies Two Days After ‘Well-Baby Visit’ Vaccinations
Peace on 15-Month-Old Girl Dies Two Days After ‘Well-Baby Visit’ Vaccinations
Rod H. on ‘Mysterious’ Pneumonia Outbreaks Reported in China
Tim on One in Five Paxlovid Users Experience COVID Rebound Infections